Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Jamroze A, Chatta G, Tang DG. Cancer Lett 2021;518:1-9.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jamroze A, Chatta G, Tang DG. Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Lett 2021;518:1-9.
PMID: 34118355